Cardiology
From the Journals
Young adults with hypertension may be at higher CVD risk
Disagreement over the ACC/AHA blood pressure guidelines threatens to distract from their potential benefits.
Feature
Heart drug spotlights troubling trends in drug marketing
Critics worry the marketing of Vascepa, a purified fish-oil product, could prove a fish story.
From the Journals
Exercise improves outcomes for patients with heart failure and OSA
Exercise alone or in addition to CPAP significantly improves quality of life for patients with heart failure and obstructive sleep apnea.
Commentary
A closer look at an ezetimibe discussion
Although I look forward to receiving JFP each month, I was initially disappointed in Dr. Jonathon M. Firnhaber’s article, “Newer...
Practice Alert Podcast
ECG to screen asymptomatic adults? Not so fast, says USPSTF
In this month’s audiocast, Dr. Campos-Outcalt details 2 US Preventive Services Task Force recommendations regarding the use of electrocardiography...
Conference Coverage
Data support revising ASCVD cardiovascular risk threshold
MUNICH – “This is very important from a public health policy perspective.” – Dr. Robert S. Rosenman
News
Canagliflozin approved for cardiovascular event risk reduction
.
From the Journals
Psoriasis adds to increased risk of cardiovascular procedures, surgery in patients with hypertension
The results suggest that hypertensive patients and psoriasis have “earlier and more aggressive disease progression of hypertension.”
Conference Coverage
Risk score validated for major NSAID adverse events
CHICAGO – Data from almost 24,000 patients on chronic NSAIDs produced a risk calculator for major NSAID-related adverse events.
News
Heart cell transplant rejections
Piero Anversa’s fraudulent research led to an NIH study in humans that is still ongoing.
Conference Coverage
High ED recidivism seen in disadvantaged populations with chest pain
SAN DIEGO – After ED visits for chest pain, lack of resources among socioeconomically disadvantaged patients may...